168 related articles for article (PubMed ID: 23641144)
1. Tumor suppressor role of notch1 and raf-1 signaling in medullary thyroid cancer cells.
Kunnimalaiyaan M; Haymart MR; Chen H
Transl Oncogenomics; 2007; 2():43-7. PubMed ID: 23641144
[TBL] [Abstract][Full Text] [Related]
2. Expression of the active Notch1 decreases MTC tumor growth in vivo.
Jaskula-Sztul R; Pisarnturakit P; Landowski M; Chen H; Kunnimalaiyaan M
J Surg Res; 2011 Nov; 171(1):23-7. PubMed ID: 21571316
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
J Biol Chem; 2006 Dec; 281(52):39819-30. PubMed ID: 17090547
[TBL] [Abstract][Full Text] [Related]
4. Medullary thyroid cancer: the functions of raf-1 and human achaete-scute homologue-1.
Chen H; Kunnimalaiyaan M; Van Gompel JJ
Thyroid; 2005 Jun; 15(6):511-21. PubMed ID: 16029117
[TBL] [Abstract][Full Text] [Related]
5. Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells.
Greenblatt DY; Cayo MA; Adler JT; Ning L; Haymart MR; Kunnimalaiyaan M; Chen H
Ann Surg; 2008 Jun; 247(6):1036-40. PubMed ID: 18520232
[TBL] [Abstract][Full Text] [Related]
6. Xanthohumol inhibits the neuroendocrine transcription factor achaete-scute complex-like 1, suppresses proliferation, and induces phosphorylated ERK1/2 in medullary thyroid cancer.
Cook MR; Luo J; Ndiaye M; Chen H; Kunnimalaiyaan M
Am J Surg; 2010 Mar; 199(3):315-8; discussion 318. PubMed ID: 20226902
[TBL] [Abstract][Full Text] [Related]
7. The role of human achaete-scute homolog-1 in medullary thyroid cancer cells.
Sippel RS; Carpenter JE; Kunnimalaiyaan M; Chen H
Surgery; 2003 Dec; 134(6):866-71; discussion 871-3. PubMed ID: 14668716
[TBL] [Abstract][Full Text] [Related]
8. Differentiation of medullary thyroid cancer by C-Raf-1 silences expression of the neural transcription factor human achaete-scute homolog-1.
Chen H; Carson-Walter EB; Baylin SB; Nelkin BD; Ball DW
Surgery; 1996 Aug; 120(2):168-72; discussion 173. PubMed ID: 8751579
[TBL] [Abstract][Full Text] [Related]
9. Neuroendocrine tumor cell growth inhibition by ZM336372 through alterations in multiple signaling pathways.
Kunnimalaiyaan M; Ndiaye M; Chen H
Surgery; 2007 Dec; 142(6):959-64; discussion 959-64. PubMed ID: 18063082
[TBL] [Abstract][Full Text] [Related]
10. Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.
Ning L; Jaskula-Sztul R; Kunnimalaiyaan M; Chen H
Ann Surg Oncol; 2008 Sep; 15(9):2600-5. PubMed ID: 18563491
[TBL] [Abstract][Full Text] [Related]
11. Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer.
Cook M; Yu XM; Chen H
Am J Transl Res; 2010 Feb; 2(1):119-25. PubMed ID: 20182588
[TBL] [Abstract][Full Text] [Related]
12. Tumor suppressor role of Notch-1 signaling in neuroendocrine tumors.
Kunnimalaiyaan M; Chen H
Oncologist; 2007 May; 12(5):535-42. PubMed ID: 17522241
[TBL] [Abstract][Full Text] [Related]
13. ZM336372, a Raf-1 activator, inhibits growth of pheochromocytoma cells.
Kappes A; Vaccaro A; Kunnimalaiyaan M; Chen H
J Surg Res; 2006 Jun; 133(1):42-5. PubMed ID: 16603190
[TBL] [Abstract][Full Text] [Related]
14. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
Ning L; Greenblatt DY; Kunnimalaiyaan M; Chen H
Oncologist; 2008 Feb; 13(2):98-104. PubMed ID: 18305053
[TBL] [Abstract][Full Text] [Related]
15. Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological induction.
Jaskula-Sztul R; Eide J; Tesfazghi S; Dammalapati A; Harrison AD; Yu XM; Scheinebeck C; Winston-McPherson G; Kupcho KR; Robers MB; Hundal AK; Tang W; Chen H
Mol Cancer Ther; 2015 Feb; 14(2):499-512. PubMed ID: 25512616
[TBL] [Abstract][Full Text] [Related]
16. In-vivo activation of Raf-1 inhibits tumor growth and development in a xenograft model of human medullary thyroid cancer.
Vaccaro A; Chen H; Kunnimalaiyaan M
Anticancer Drugs; 2006 Aug; 17(7):849-53. PubMed ID: 16926634
[TBL] [Abstract][Full Text] [Related]
17. Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells.
Arthan D; Hong SK; Park JI
Cancer Lett; 2010 Nov; 297(1):31-41. PubMed ID: 20570039
[TBL] [Abstract][Full Text] [Related]
18. ZM336372, a Raf-1 activator, suppresses growth and neuroendocrine hormone levels in carcinoid tumor cells.
Van Gompel JJ; Kunnimalaiyaan M; Holen K; Chen H
Mol Cancer Ther; 2005 Jun; 4(6):910-7. PubMed ID: 15956248
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.
Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
J Surg Res; 2010 Apr; 159(2):640-4. PubMed ID: 19394967
[TBL] [Abstract][Full Text] [Related]
20. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM
Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
